|
1
|
(HPO:0000006)
|
Autosomal dominant inheritance |
|
|
|
|
2518 / 7739
|
|
2
|
(HPO:0001025)
|
Urticaria |
|
|
|
|
73 / 7739
|
|
3
|
(HPO:0001744)
|
Splenomegaly |
|
|
|
|
337 / 7739
|
|
4
|
(HPO:0001880)
|
Eosinophilia |
|
|
|
|
35 / 7739
|
|
5
|
(HPO:0001890)
|
Autoimmune hemolytic anemia |
|
|
|
|
17 / 7739
|
|
6
|
(HPO:0001891)
|
Iron deficiency anemia |
|
|
|
|
22 / 7739
|
|
7
|
(HPO:0001904)
|
Autoimmune neutropenia |
|
|
|
|
5 / 7739
|
|
8
|
(HPO:0001973)
|
Autoimmune thrombocytopenia |
|
|
|
|
18 / 7739
|
|
9
|
(HPO:0002240)
|
Hepatomegaly |
|
|
|
|
467 / 7739
|
|
10
|
(HPO:0002633)
|
Vasculitis |
|
|
|
|
12 / 7739
|
|
11
|
(HPO:0002729)
|
Follicular hyperplasia |
|
|
|
|
5 / 7739
|
|
12
|
(HPO:0002730)
|
Chronic noninfectious lymphadenopathy |
|
|
|
|
3 / 7739
|
|
13
|
(HPO:0002731)
|
Decreased lymphocyte apoptosis |
|
|
|
|
4 / 7739
|
|
14
|
(HPO:0002845)
|
Increased number of peripheral CD3+ T cells |
|
|
|
|
3 / 7739
|
|
15
|
(HPO:0002851)
|
Increased number of CD4-/CD8- T cells expressing alpha/beta T-cell receptors |
|
|
|
|
3 / 7739
|
|
16
|
(HPO:0002853)
|
Increased proportion of HLA DR+ and CD57+ T cells |
|
|
|
|
3 / 7739
|
|
17
|
(HPO:0002923)
|
Rheumatoid factor positive |
|
|
|
|
5 / 7739
|
|
18
|
(HPO:0002972)
|
Reduced delayed hypersensitivity |
|
|
|
|
7 / 7739
|
|
19
|
(HPO:0003237)
|
Increased IgG level |
|
|
|
|
5 / 7739
|
|
20
|
(HPO:0003261)
|
Increased IgA level |
|
|
|
|
12 / 7739
|
|
21
|
(HPO:0003262)
|
Smooth muscle antibody positivity |
|
|
|
|
3 / 7739
|
|
22
|
(HPO:0003453)
|
Antineutrophil antibody positivity |
|
|
|
|
3 / 7739
|
|
23
|
(HPO:0003454)
|
Platelet antibody positive |
|
|
|
|
4 / 7739
|
|
24
|
(HPO:0003493)
|
Antinuclear antibody positivity |
|
|
|
|
15 / 7739
|
|
25
|
(HPO:0003496)
|
Increased IgM level |
|
|
|
|
8 / 7739
|
|
26
|
(HPO:0003613)
|
Antiphospholipid antibody positivity |
|
|
|
|
4 / 7739
|
|
27
|
(HPO:0004844)
|
Coombs-positive hemolytic anemia |
|
|
|
|
5 / 7739
|